Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910307 · ClinicalTrials.gov registry record
Synovial Sarcoma Registry / Biospecimen Repository
A clinical trial of Synovial Sarcoma, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05910307 is a study of Synovial Sarcoma that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,000 participants, above the 66-participant average among 11 other Synovial Sarcoma trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05910307, a study of Synovial Sarcoma, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tumor tissue and may be asked to give a blood or saliva sample. Participants will also be asked to completed questionnaires about their medical history and may be contacted every 6 to 12 months for updates for up to 10 years.
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2033-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05910307
The ClinicalTrials.gov registry entry for NCT05910307 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 66-participant average among 11 other Synovial Sarcoma trials with a reported enrollment target (1415% higher). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Synovial Sarcoma appearing as the primary indexed condition, and to 0 interventions.
NCT05910307 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05910307 about?
NCT05910307 is a clinical study titled "Synovial Sarcoma Registry / Biospecimen Repository". The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tum...
What is the current status of trial NCT05910307?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-06-12. Estimated completion is 2033-06.
What conditions does trial NCT05910307 study?
This clinical trial studies the following conditions: Synovial Sarcoma.
Who is sponsoring clinical trial NCT05910307?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05910307 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Synovial Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
RECRUITING · Phase 1
-
ACTengine® IMA203 Combined With mRNA-4203
RECRUITING · Phase 1
-
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RECRUITING · Phase 1
-
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RECRUITING · Phase 1
-
SPEARHEAD-3 Pediatric Study
RECRUITING · Phase 1
-
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.